Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
First, he's not necessarily using $400K/mo. There will be some measure of itemization for you in the next 10-Q.
Lease
Salaries for 7 employees.
Corporate expenses (subsidiary, patents, etc.)
Drug formulation
Preclinical work
Attorneys for deal making (the one that is very, very close)
Lots of stuff going on.
Of course. And someone is buying them.
PPS is fine. It's being whittled away by traders who are trying to load up cheap for the next run to 0.40 or a deal announcement. I personally welcome the volatility after essentially being locked into 0.13 + or - a nickel for 8 months straight.
It was a good amount for a flat day.
Buying time, then Miller time!
If we make it to $0.75 and have the balance sheet shored up ready to move into a phase 3 and another phase 2 I'll be quite happy considering all the shares below $0.20 I picked up. $1+ starts getting into generational wealth territory. Very possible, very soon. Hard not to be excited.
Eh maybe. It ran on a whim and then we had a financing bridge deal followed by a term-sheet announcement that week and the following week. More like on a leak than a whim in my opinion.
Anything is possible I guess. That recent run up was likely news of a financing deal and/or the term sheet. Someone caught wind of one of those two...we didn't run to $0.42 on a whim.
I agree that any but the worst deals will bring us back to $1.
What circumstance do you envision can bring us to $1 absent a deal (or relating leak)? We can't do any more significant pipeline work and management can't get any closer to signing a deal than "finalizing a definitive agreement" on a term sheet.
I think it would be a very bad deal if that were the case. $300MM is not out of line with where our pipeline is if we clear up all balance sheet issues with $20M+ upfront. Remember, we have very little forward-looking enthusiasm built into the stock.
I believe it was you or someone else that stated a $30-40M market cap, given our pipeline, is indicative of a market that does not believe we can get a deal done.
Getting third-party validation along with a clean balance sheet would allow our market cap to appreciate to a more suitable level around $300MM.
And if we actually get $50M-100M upfront...well we'll blow right through $1.
What do board members have to do with a deal? IPIX was twice this price just weeks ago. When a deal gets signed we will probably hit $1 and never look back. Coming this year...where else will you get a 5x in 6 months?
Hang in there IPIXers! A deal is coming soon. Only a question of when and how much the stock moves. 3x? 5x? 10x?
Probably coming by the end of summer. Almost certainly this year.
It's all going to be ok. We have plenty of funding secured through November to finalize a definitive pipeline agreement with a partner. That will result in large returns from here, likely this year.
Yuge gains comong to IPIX very shortly.
A deal will be great for IPIX shareholders. It will be salvation for the company and will put us on the road to prosperity and profit.
Nonsense. An IPIX deal is practically in the bag. Very soon.
It's almost like an Irish subsidiary is a serious precursor to a large pharma deal.
Anyone who doesn't have at least a little IPIX in their high-risk account is missing one hell of a payout on a coin toss here.
Remember the Theravance deal from last year for an oral IBD treatment going into a phase 2b/3 trial...
$100M upfront with $900M in milestones.
Big $$$ coming to IPIX soon.
$200M was a typo. Meant $20M. The rest still stands.
Also, yes it is unlikely we will see $200M upfront but one never knows.
False. They have been trying to bring success to shareholders for years and are on the cusp of signing a lucrative business development deal for B-UP.
Large upside for here for IPIX. Very large.
The risk is small. Quite small.
I think that would be a pretty bad deal and don't see it as likely. I'm thinking $20M-$40M plus trial costs is likely where it will end up.
Can you do that math for me? A company with a $45M market cap receives $200M upfront and you expect the market cap to decrease?
Doesnt seem to make much sense to me.
They won't have to wait long for huge returns. Negotiations are being finalized as we speak. Only a question of when the announcement drops and how high will the stock go on that day? 2x? 3x? 5x?
We can get above $1 real fast if there is enough upfront. 300% on shares bought today inside of 6 months aint too shabby.
It's a prediction. You know...sometimes you look back and they were fact all along.
Not this week. The week of the deal. Which could be this week. Probably not, but could be.
Probably false.
It will likely end the week up over 100%. All depends on the deal terms. If we get $50-$100 million upfront it could end the week up 1000%.
Plenty of funding available for keeping the lights on. 400K a month until November. If this term sheet fails it means a little more dilution, not death.
No need to be overly dramatic.
Even of we dont have one that ultimately succeeds we should get a nice return on just the partnership upfront. It's not far away and could result in 200-500% gains the day of the announcement.
IPIX management has never been clearer with regard to a deal. There is no new data coming and they have every incentive to do a deal. Unless one truly believes we have nothing worthy of partnership, then partnership is the only next step.
The next announcement of substance will be the signing of a deal.
That is the most definitive statement we have seen from IPIX with regard to deal making. It should not be taken lightly.
$IPIX A deal is coming.
What are you talking about? Mako never brought a lawsuit against IPIX or shareholders. Why are you writing things that never happened about the company?
What has changed since Leo told you this? Not the trial results.
In post 252982 you stated: "...Leo's lowest current offer is indicating that B-OM is worth $150M/yr..."
So nothing to worry about, right? $150M/yr worst case, right?
I was referring to the new funding agreement we recently established, not a partnership deal. Refer to the 8K on 5/10. We are covered for 6 months against sudden death.
False.
We just established a new funding mechanism. Additionally, with our recently reinvigorated stock price, we could last for years while there are no clinical trials running. The recent stock run and funding agreement has ensured that there will be no sudden death for IPIX. This is pure FUD.
Wrong again. The upfront and milestone payment are simply income for the company. Any money reserved for development costs of UP will be earmarked in the deal terms.
An imporrant point with refars to Celgene.
If it was a hard pass they wouldnt have arrived to a term sheet in the first place.
My guess is that without BTD they werent paying what Leo thinks it is worth so he is pursuing the UP deal to get funding for the OM trial. With more data we will be able to negotiate the deal we are looking for.
You speak in half truths.
It looks like the FDA did not grant BTD. They seem to be fine with proceeding to phase 3.
The first term sheet may not have been inked sue to a variety of reasons. Perhaps they weren't paying enough.
You really need to review the primary, secondary, and historical placebo rates for OM. What you're saying is not at all representative of the results.
You wouldn't be saying that if you got around to looking at those secondary endpoints we discussed yesterday. They are highly informative. You should really go take a second look over all the results and endpoints. You might be a little more enthusiastic about B-OM if you do.